7608
S. Takamatsu et al. / Tetrahedron Letters 42 (2001) 7605–7608
In conclusion, hypophosphorous acid and dialkyl phos-
phites are effective radical reducing agents for O-thio-
carbonyl groups, as in xanthates and thiocarbonates, or
halides at the sugar part of nucleoside derivatives to
give the corresponding hydrocarbons in high yields.
The present method is useful for the synthesis of vari-
ous 2%-deoxy or 3%-deoxynucleoside derivatives, includ-
ing FddA and 2%-deoxyadenosine.
9. (a) Takamatsu, S.; Katayama, S.; Hirose, N.; Izawa, K.
European Patent Application EP0999218, 2000; (b) Taka-
matsu, S.; Katayama, S.; Hirose, N.; Izawa, K. Japanese
Patent Application JP2000-198796, 2000.
10. A representative experimental procedure is as follows: 5
(6.60 g, 12.9 mmol) was dissolved in DMSO (52.4 ml) and
cooled to 12°C. To this were added 5M sodium hydroxide
(2.84 ml, 14.2 mmol) and carbon disulfide (3.09 ml, 51.6
mmol) at 15°C. After stirring for 15 min at 15°C, methyl
iodide (1.60 ml, 25.7 mmol) was added to the mixture. The
resulting mixture was poured into water (80 ml) and ethyl
acetate (80 ml) with vigorous stirring. The reaction mixture
was separated into layers, and the organic layer was
washed with water (80 ml). The organic layer was concen-
trated under reduced pressure to give an oily residue. The
residue was crystallized from acetonitrile (50 ml). The
resulting crystals were filtered and dried at 50°C under
reduced pressure to give the desired product (7.32 g, 91.8%
purity, 11.2 mmol, 86.6% yield).
Acknowledgements
The authors thank Professor Tokumi Maruyama of
Tokushima Bunri University for scientific discussion
and help in preparation of the manuscript. We are also
grateful to Mr. Hideo Takeda and Mr. Shigekatsu
Tsuchiya of Ajinomoto Co., Inc. for their technical
assistance.
11. McAtee, J. J.; Schinazi, R. F.; Liotta, D. C. J. Org. Chem.
1998, 63, 2161–2167.
References
12. A representative experimental procedure is as follows: To
a solution of 6 (102 mg, 98.0% purity, 0.166 mmol) in
DME (0.83 ml) were added Et3N (0.255 ml, 1.83 mmol)
and 50% aqueous H3PO2 (0.172 ml, 1.66 mmol). This
mixture was heated until reflux and AIBN (16.4 mg, 0.0997
mmol) dissolved in DME (0.49 ml) was added in three
portions. After stirring for 1.8 h at reflux, the reaction
mixture was cooled to room temperature, treated with
dichloromethane (5 ml) and water (5 ml), and separated
into layers. The organic layer was concentrated under
reduced pressure to give a solid residue. HPLC analysis
showed that the desired product was obtained in 93.0%
yield (76.5 mg, 0.154 mmol).
13. A representative experimental procedure is as follows: To
a solution of 6 (61.4 mg, 98.0% purity, 0.100 mmol) in
DME (1.0 ml) was added (MeO)2P(O)H (110 mg, 1.00
mmol). This mixture was heated until reflux, and AIBN
(10.0 mg, 0.0600 mmol) dissolved in DME (0.60 ml) was
added in three portions. After stirring for 2 h at reflux, the
reaction mixture was cooled to rt and concentrated under
reduced pressure to give a solid residue. HPLC analysis
showed that the desired product was obtained in 84.1%
yield (41.7 mg, 0.0841 mmol).
14. A representative experimental procedure is as follows: To
a solution of 50% aqueous H3PO2 (15.5 ml, 150 mmol) in
water (104 ml) was added Et3N (21.0 ml, 151 mmol) at
16°C. The resulting solution was added to a solution of 8
(20.8 g, 50.0 mmol) in CH3CN (38.7 ml). This mixture was
heated to 43°C, and added Et3N (3.82 ml, 27.4 mmol) to
raise the pH value from 3.8 to 8.0. This mixture was heated
to 50°C and VA-044™ (1.62 g, 5.00 mmol) dissolved in
water (8.3 ml) was added. After stirring for 30 min at 50°C,
the reaction mixture was neutralized to pH 4.0 with 25%
aqueous sodium hydroxide (3.54 g, 22.1 mmol). After
additional stirring for 1.5 h at 50°C, the reaction mixture
was cooled to 10°C, and neutralized to pH 6.0 with 25%
aqueous sodium hydroxide (5.94 g, 37.1 mmol). HPLC
analysis showed that the desired product was obtained in
99.2% yield (16.7 g, 49.6 mmol).
1. (a) Robins, M. J.; Wilson, J. S. J. Am. Chem. Soc. 1981,
103, 932–933; (b) Robins, M. J.; Wilson, J. S.; Hansske,
F. J. Am. Chem. Soc. 1983, 105, 4059–4065.
2. Barton, D. H. R.; McCombie, S. W. J. J. Chem. Soc.,
Perkin Trans. 1 1975, 1574–1585.
3. (a) Hartwig, W. Tetrahedron 1983, 39, 2609–2645; (b)
Ramaiah, M. Tetrahedron 1987, 43, 3541–3676; (c) Moth-
erwell, W. B.; Crich, D. Free Radical Chain Reactions in
Organic Synthesis; Academic Press: London, 1992; Chap-
ter 3, pp. 29–129.
4. (a) Maruyama, T.; Takamatsu, S.; Kozai, S.; Satoh, Y.;
Izawa, K. Chem. Pharm. Bull. 1999, 47, 966–970; (b)
Takamatsu, S.; Maruyama, T.; Katayama, S.; Hirose, N.;
Izawa, K. Tetrahedron Lett. 2001, 42, 2321–2324; (c)
Takamatsu, S.; Maruyama, T.; Katayama, S.; Hirose, N.;
Naito, M.; Izawa, K. Tetrahedron Lett. 2001, 42, 2325–
2328; (d) Takamatsu, S.; Maruyama, T.; Katayama, S.;
Hirose, N.; Naito, M.; Izawa, K. J. Org. Chem., accepted.
5. (a) Marquez, V. E.; Tseng, C. K.-H.; Kelley, J. A.;
Mitsuya, H.; Broder, S.; Roth, J. S.; Driscoll, J. S.
Biochem. Pharmacol. 1987, 36, 2719–2722; (b) Herdewijn,
P.; Pauwels, R.; Baba, M.; Balzarini, J.; De Clercq, E. J.
Med. Chem. 1987, 30, 2131–2137; (c) Marquez, V. E.;
Tseng, C. K.-H.; Mitsuya, H.; Aoki, S.; Kelley, J. A.; Ford,
Jr., H.; Roth, J. S.; Broder, S.; Johns, D. G.; Driscoll, J.
S. J. Med. Chem. 1990, 33, 978–985; (d) Ruxrungtham, K.;
Boone, E.; Ford, Jr., H.; Driscoll, J. S.; Davey, Jr., R. T.;
Lane, H. C. Antimicrob. Agents Chemother. 1996, 40,
2369–2374 and references cited therein; (e) Graul, A.;
Silvestre, J. Drugs Future 1998, 23, 1176–1189 and refer-
ences cited therein.
6. (a) Chatgilialoglu, C. Acc. Chem. Res. 1992, 25, 188–194;
(b) Chatgilialoglu, C.; Ferreri, C. Res. Chem. Intermed.
1993, 19, 755–775.
7. Barton, D. H. R.; Jang, D. O.; Jaszberenyi, J. Cs. Tetra-
hedron Lett. 1992, 33, 2311–2314.
8. (a) Barton, D. H. R.; Jang, D. O.; Jaszberenyi, J. Cs.
Tetrahedron Lett. 1992, 33, 5709–5712; (b) Barton, D. H.
R.; Jang, D. O.; Jaszberenyi, J. Cs. J. Org. Chem. 1993, 58,
6838–6842.
15. Markiewicz, W. T. J. Chem. Res. (S) 1979, 24–25.